Floatz logo

101 assets in Migraine Disorder

Therapeutic assets addressing Migraine Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Atogepant
Migraine Disorder
Stanford UniversityP4A (87)
Naproxen
Migraine Disorder
IRCCS San Raffaele RomaP4A (80)
Rizatriptan
Migraine Disorder
Antonios LikourezosP4A (80)
Dfn-11 (Sumatriptan Injection)
Migraine Disorder
IRCCS San Raffaele RomaP4BBB (79)
Eptinezumab
Migraine Disorder
Stanford UniversityP4BBB (79)
Ubrogepant
Migraine Disorder
H. Lundbeck A/SP4BBB (79)
Galcanezumab
Migraine Disorder
Stanford UniversityP4BBB (78)
Lidocaine
Migraine Disorder
Mahidol UniversityP4BBB (75)
Rimegepant
Migraine Disorder
PfizerP4BBB (75)
Apsolol
Migraine Disorder
Chittagong Medical CollegeP4BBB (74)
Fremanezumab
Migraine Disorder
University of AarhusP4BBB (74)
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer
Migraine Disorder
Stanford UniversityP4BBB (74)
Lasmiditan
Migraine Disorder
Hospital Clínico Universitario de ValladolidP3BBB (74)
Marcaine
Migraine Disorder
Cairo UniversityP4BBB (74)
Prochlorperazine
Migraine Disorder
Washington University School of MedicineP4BBB (74)
Topiramate
Migraine Disorder
Stanford UniversityP4BBB (74)
Dexasone
Migraine Disorder
Texas Tech University Health Sciences Center, El PasoP4BBB (73)
Aspirin
Migraine Disorder
Cairo UniversityP4BBB (72)
Caffeine
Migraine Disorder
Ain Shams UniversityP4BBB (72)
Ibuprofen
Migraine Disorder
Cairo UniversityP4BBB (72)
Ketorolac
Migraine Disorder
Health Sciences North Research InstituteP4BBB (72)
Piperazine, 1-(Bis(4-Fluorophenyl)Methyl)-4-(3-Phenyl-2-Propenyl)-, (E)-
Migraine Disorder
Chittagong Medical CollegeP4BBB (72)
Metoclopramide
Migraine Disorder
Health Sciences North Research InstituteP4BB (71)
Naltrexone
Migraine Disorder
Allodynic Therapeutics, IncP2/3BB (70)
Valproic Acid
Migraine Disorder
Kafrelsheikh UniversityP4BB (70)
Zavegepant
Migraine Disorder
University of South FloridaP4BB (70)
Fentanyl
Migraine Disorder
Washington University School of MedicineP4BB (69)
Lacosamide
Migraine Disorder
Kafrelsheikh UniversityP3BB (67)
Clopidogrel
Migraine Disorder
Chinese Academy of Medical Sciences, Fuwai HospitalP4BB (66)
Diphenhydramine
Migraine Disorder
Washington University School of MedicineP4BB (66)
Elismetrep
Migraine Disorder
Kallyope Inc.P3BB (66)
Onabotulinum Toxin A
Migraine Disorder
University of AlbertaP4BB (66)
Amitriptyline
Migraine Disorder
Stanford UniversityP4BB (65)
Candesartan
Migraine Disorder
Stanford UniversityP4BB (65)
Canvert-M
Migraine Disorder
Alasht PharmedP4BB (65)
Dexketoprofen
Migraine Disorder
Suleyman Demirel UniversityP4BB (65)
Magnesium Metallicum
Migraine Disorder
Wake Forest University Health SciencesP4BB (65)
Hydromorphon
Migraine Disorder
Washington University School of MedicineP4B (63)
Idebenone
Migraine Disorder
Beijing Tiantan HospitalP4B (63)
Oxygen
Migraine Disorder
Centre Hospitalier Universitaire de NiceP4B (63)
Zonisamide
Migraine Disorder
Kafrelsheikh UniversityP4B (63)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Migraine Disorder
Assiut UniversityP4B (62)
Rivaroxaban
Migraine Disorder
Chinese Academy of Medical Sciences, Fuwai HospitalP3B (62)
Ighv3-66*01 (81.4%) -(Ighd) -Ighj1*01 (100%), Cdr-Imgt [8.7.6] (26-33.51-57.96-101)) (1-112) -Homo Sapiens Ighg1*03V, G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14, 8-G1V29 Ch2 A84.4 (Ch1 R120>K (209) (113-210), Hinge 1-15 (211-225), Ch2 N84.4>A (292) (226-335), Ch3 E12 (351), M14 (353) (336-440), Chs (441-442)) (113-442)], (215-216')-Disulfide With L-Kappa Light Chain Humanized (1'-216') [V-Kappa (Homo Sapiens Igkv1-5*01 (85.4%) -Igkj1*01 (90.0%) Q120>G (102'), Cdr-Imgt [7.3.10] (27'-33'.51'-53'.90'-99')) (1'-109') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappa A45.1 (155'), V101 (193')) (110'-216')]; Dimer (221-221'':224-224'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-Dg44, Non-Glycosylated
Migraine Disorder
H. Lundbeck A/SP2B (61)
Noramitriptyline
Migraine Disorder
Stanford UniversityP4B (61)
Gou-Teng-San
Migraine Disorder
Tsai, Chueh-Yi, MDP3B (60)
Incobotulinumtoxina
Migraine Disorder
Uniformed Services University of the Health SciencesP3B (60)
Meloxidolor
Migraine Disorder
Axsome Therapeutics, Inc.P3B (60)
Xeomin®
Migraine Disorder
Merz Therapeutics GmbHP3B (60)
Mig-Spray
Migraine Disorder
University Hospital, Clermont-FerrandP4B (59)
Showing 1 to 50 of 101 assets
PreviousPage 1 of 3Next